CXR Biosciences
Snodland
About CXR Biosciences
CXR Biosciences is advancing and commercializing innovative approaches to transform the drug development and chemical safety assessment process. As well as introducing new technology platforms to the marketplace, CXR also helps customers to take their candidate compounds through development efficiently, or to resolve problems that have been encountered, through the provision of customized solutions. The company has business relationships with over sixty customers and collaborators, including pharmaceutical companies, chemical companies, biotechnology companies, leading universities and research institutions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $2.6M
- Funding stage: M&A
- Last round: Series Unknown (Feb 2008)
- Website: cxrbiosciences.com
- Phone: 441382432153
Industries & Categories
Biotechnology, Information Technology
Social Profiles
Canonical: https://fsome.com/organization/cxr-biosciences-1317817 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.